Indrayani Biotech Fair Value
Indrayani Biotech (INDRANIB) average fair value is ₹20.54 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹7.84 (+161.94%), fair value range ₹2.04–₹57.61. Check Indrayani Biotech market worth to track the company's total market size over time.
Fair Value Analysis Export
INDRANIB Fair Value vs Current Price — Valuation Summary
INDRANIB average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
INDRANIB Fair Value Analysis — Data Sources & Coverage
Indrayani Biotech financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. For live price and a broader fundamental view, visit INDRANIB screener.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
INDRANIB vs FMCG Sector Peers — P/E, P/B & Market Cap
Indrayani Biotech P/E ratio, P/B ratio and market capitalisation vs FMCG sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Swasth Foodtech | SWASTH | -7.0 | 0.47 | ₹10 |
| Shreeji Global FMCG | SHETHJI | - | 3.2 | ₹351 |
| Patanjali Foods | PATANJALI | 20.86 | 2.89 | ₹36,745 |
| KCK Industries | KCK | 227.86 | 3.55 | ₹102 |
| Kwality Walls | KWIL | -25.26 | 11.12 | ₹7,474 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.